Ray Dalio's ADPT Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 265,491 shares of Adaptive Biotechnologies Corporation (ADPT) worth $4.31 M, representing 0.02% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in ADPT, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 114,237 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Adaptive Biotechnologies Corporation (ADPT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Adaptive Biotechnologies Corporation (ADPT) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +114,237 | Add 75.53% | 265,491 | $16.24 |
| Q3 2025 | +151,254 | New Buy | 151,254 | $14.96 |
Ray Dalio's Adaptive Biotechnologies Corporation Investment FAQs
Ray Dalio first purchased Adaptive Biotechnologies Corporation (ADPT) in Q3 2025, acquiring 151,254 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Adaptive Biotechnologies Corporation (ADPT) for 2 quarters since Q3 2025.
Ray Dalio's largest addition to Adaptive Biotechnologies Corporation (ADPT) was in Q3 2025, adding 151,254 shares worth $2.26 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 265,491 shares of Adaptive Biotechnologies Corporation (ADPT), valued at approximately $4.31 M.
As of the Q4 2025 filing, Adaptive Biotechnologies Corporation (ADPT) represents approximately 0.02% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Adaptive Biotechnologies Corporation (ADPT) was 265,491 shares, as reported at the end of Q4 2025.